Clinical trial
Double-Blind Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
NCT00375518 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- May 31, 2014
- Enrollment
- 162 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thoracic surgery